Company News & Press

27 October 2021

Metabolon Advances Metabolomics Innovation with New SmartPanel™ Portfolio

Metabolon’s Microbiome SmartPanel demystifies the gut microbiome by zeroing in on biologically relevant microbial and host-derived metabolites, along with xenobiotic molecules, to reveal deep insight into microbiome function and its impact on host health. The proprietary Heliogram™ visualization tool allows users to explore 13 microbiome pathways for rapid connectivity to the impact of therapeutic interventions on the host microbiome.

15 October 2021

Metabolon Continues Investments in Scientific Innovation with Appointment of Rangaprasad (Ranga) Sarangarajan, Ph.D., in New Leadership Role as Chief Scientific Officer

Dr. Sarangarajan supports Metabolon’s mission to deliver metabolomics data and insights that expand and accelerate the impact of life sciences research in all its applications by leading the team to identify R&D applications across biopharma and diagnostics.

7 June 2021

Metabolon Strengthens Leadership with Two New Executives to Support Long-Term Growth Transformation

Metabolon has named two new executives to support its mission to become a diversified leader in healthcare: Florina Krawchick, SPHR, CPC, Vice President, Global Head of Human Resources and J. Kevin Day, Ph.D., HCLD (ABB)., Vice President, Operations.

17 May 2021

The Healthcare Technology Report names Rohan F. Hastie a Top 50 Healthcare Technology CEO of 2021

Dr. Hastie has been at the helm of Metabolon since 2018, when initiated the company’s efforts to dramatically expand awareness and application of metabolomics in the biopharma market, setting a vision of enlightening life and enabling a healthier world.

18 February 2021

Metabolon Collaborates with Cleveland Clinic to Enable Novel Discoveries

Metabolon, Inc. has entered into a multi-year collaborative agreement with Cleveland Clinic to provide Metabolon’s Precision Metabolomics™ services in support of drug development and related research efforts. Metabolon will leverage its proprietary platform to analyze a range of biologic samples to help discover metabolomic biomarkers that will deepen understanding of Cleveland Clinic’s novel discoveries, improve speed of decision-making and accelerate clinical trials.

23 November 2020

National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study

“We are honored to partner with NIAID and Metabolon in this effort to define how the human response to SARS-CoV-2 correlates to COVID severity and outcome. Metabolic features of the immune responses are increasingly recognized as pivotal to disease and health, and we are fortunate to have Metabolon’s excellent team by our side as we undertake this critical work.” – Dr. Ofer Levy, Director of the Precision Vaccines Program (PVP) at Boston Children’s Hospital

23 September 2020

Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies

New and existing investors contributed to biotech’s largest ever capital raise; company also announced appointment of Robert A. Cascella, Chief Business Leader, Precision Diagnostics, and Executive Vice President of Phillips, as one of three independent members of the Metabolon Board of Directors.

6 August 2020

Metabolon, Inc. Joins SOPHIA, International Research Consortium

Metabolon will perform metabolomics on study participants as part of the five-year longitudinal study to improve risk assessment of complications of obesity, supporting greater understanding in patient stratification for the right treatment depending on metabolic profiles.

3 August 2020

Metabolon Announces Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany

Metabolomic insights will support the leading science and technology company in advancement of its drug early development programs across therapeutic areas.

22 June 2020

Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics

OMNImet™·GUT expands access to critical metabolomic analysis with development of in-home fecal collection device – the first device for in-home collection and ambient-temperature storage and shipping of fecal samples for metabolomics, to the research market.

Find Us at These Events

Watch On-Demand Webinars

27 October 2021

Metabolon Advances Metabolomics Innovation with New SmartPanel™ Portfolio

15 October 2021

Metabolon Continues Investments in Scientific Innovation with Appointment of Rangaprasad (Ranga) Sarangarajan, Ph.D., in New Leadership Role as Chief Scientific Officer

7 June 2021

Metabolon Strengthens Leadership with Two New Executives to Support Long-Term Growth Transformation

17 May 2021

The Healthcare Technology Report names Rohan F. Hastie a Top 50 Healthcare Technology CEO of 2021

18 February 2021

Metabolon Collaborates with Cleveland Clinic to Enable Novel Discoveries

23 November 2020

National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study

23 September 2020

Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies

6 August 2020

Metabolon, Inc. Joins SOPHIA, International Research Consortium

3 August 2020

Metabolon Announces Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany

Metabolomic insights will support the leading science and technology company in advancement of its drug early development programs across therapeutic areas.

22 June 2020

Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics

Enlighten your research,
accelerate your discovery.

Demo Our Data

Contact Us

Talk with an expert

Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.

Get a Project Quote

Send a Message

Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709

+1 (919) 572-1711

+1 (919) 572-1721

International Headquarters

Metabolon GmbH

Zeppelinstraße 3
85399 Hallbergmoos
Germany

+49 89 99017752

Company News & Press

Find Us at These Events

Enlighten your research, accelerate your discovery.

Contact Us

Talk with an expert

Sign up for our newsletter

Enlighten your research,
accelerate your discovery.